Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application

Advancements in biomaterial science and available cell sources have spurred the translation of tissue-engineering technology to the bedside, addressing the pressing clinical demands for replacement cardiovascular tissues. Here, the in vivo status of tissue-engineered blood vessels, heart valves, and...

Full description

Saved in:
Bibliographic Details
Published inPhysiology (Bethesda, Md.) Vol. 31; no. 1; pp. 7 - 15
Main Authors Best, Cameron, Onwuka, Ekene, Pepper, Victoria, Sams, Malik, Breuer, Jake, Breuer, Christopher
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.01.2016
Subjects
Animals
Biocompatible Materials - therapeutic use
Cardiovascular System - physiopathology
Humans
Reviews
Tissue Engineering
Online AccessGet full text

Cover

More Information
Summary:Advancements in biomaterial science and available cell sources have spurred the translation of tissue-engineering technology to the bedside, addressing the pressing clinical demands for replacement cardiovascular tissues. Here, the in vivo status of tissue-engineered blood vessels, heart valves, and myocardium is briefly reviewed, illustrating progress toward a tissue-engineered heart for clinical use.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1548-9213
1548-9221
DOI:10.1152/physiol.00018.2015